USPTO serial 99703987
OZABIO
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- LE, KIEU-NHI NGOC
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OZABIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Aldie, VA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Renuka Rajan
Renuka Rajan Rajan IPIndira Gandhi St, K K NagarPlot No. 431, First FloorTrichy, TN, 620021Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Vitamins for use in the manufacture of pharmaceuticals; Vitamins for use in the manufacture of food supplements; Vitamins for the food industry; Vitamins for manufacturing use; Excipients for use in the manufacture of pharmaceutical preparations, veterinary preparations; Glutamic acid as raw materials for use in the manufacture of cosmetics; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating general health conditions; Antioxidants for use in the manufacture of pharmaceuticals; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Carbohydrates used as an ingredient in the manufacture of nutraceuticals; Chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics; Chemical additives for use in the manufacture of pharmaceuticals; Chemically activated adhesive label for sensing the presence of oxygen in intravenous medical and pharmaceutical containers; Date seed oil for use in the manufacture of cosmetics, pharmaceutical preparations, veterinary preparations; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Enzymes for use in the manufacture of nutraceuticals; Excipients for use in the manufacture of use in the manufacture of pharmaceuticals, cosmetics; Perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; Plant extracts for use in the manufacture of creams, lotions and cosmetic products; Plant extracts for use in the manufacture of pharmaceuticals; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Sodium hyaluronate for use in the manufacture of use in the manufacture of pharmaceuticals, cosmetics; Tea extracts for use in the manufacture of pharmaceuticals | ACTIVE | Sep 26, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 10, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 10, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 8, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 16, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 15, 2026 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 15, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 25, 2026 | NWAP | NEW APPLICATION ENTERED | — |